Merck Fosamax Appeal Faces Uncertain Odds In High Court
On a U.S. Supreme Court with a recent retirement and a recusal, Merck's appeal of a Third Circuit decision reviving multidistrict litigation over the drug company's alleged failure to warn about...To view the full article, register now.
Already a subscriber? Click here to view full article